Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin
Authors
Keywords
-
Journal
Cell Communication and Signaling
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-08
DOI
10.1186/s12964-021-00731-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reducing Senescent Cell Burden in Aging and Disease
- (2020) Robert J. Pignolo et al. TRENDS IN MOLECULAR MEDICINE
- Transient metabolic improvement in obese mice treated with navitoclax or dasatinib/quercetin
- (2020) Arantzazu Sierra-Ramirez et al. Aging-US
- Senescence-like phenotype in post-mitotic cells of mice entering middle age
- (2020) Marco Raffaele et al. Aging-US
- Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan
- (2020) Laurent Grosse et al. Cell Metabolism
- Cold Press Pomegranate Seed Oil Attenuates Dietary-Obesity Induced Hepatic Steatosis and Fibrosis through Antioxidant and Mitochondrial Pathways in Obese Mice
- (2020) Marco Raffaele et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The senescence-associated secretome as an indicator of age and medical risk
- (2020) Marissa J. Schafer et al. JCI Insight
- Obesity-Induced Cellular Senescence Drives Anxiety and Impairs Neurogenesis
- (2019) Mikolaj Ogrodnik et al. Cell Metabolism
- Heme Oxygenase-1 Inhibition Sensitizes Human Prostate Cancer Cells towards Glucose Deprivation and Metformin-Mediated Cell Death
- (2019) Marco Raffaele et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of senescence in the development of non-alcoholic fatty liver disease and progression to non-alcoholic steatohepatitis
- (2019) Alkistis-Maria Papatheodoridi et al. HEPATOLOGY
- SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
- (2019) Heike Fuhrmann-Stroissnigg et al. Jove-Journal of Visualized Experiments
- Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
- (2019) LaTonya J. Hickson et al. EBioMedicine
- Cellular Senescence: Defining a Path Forward
- (2019) Vassilis Gorgoulis et al. CELL
- To help aging populations, classify organismal senescence
- (2019) Stuart R. G. Calimport et al. SCIENCE
- Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future
- (2018) Ana Ruth Araújo et al. LIVER INTERNATIONAL
- Senolytics improve physical function and increase lifespan in old age
- (2018) Ming Xu et al. NATURE MEDICINE
- N-Acetylcysteine (NAC) Ameliorates Lipid-Related Metabolic Dysfunction in Bone Marrow Stromal Cells-Derived Adipocytes
- (2018) Marco Raffaele et al. Evidence-based Complementary and Alternative Medicine
- Senolytic Cocktail Dasatinib+Quercetin (D+Q) Does Not Enhance the Efficacy of Senescence-Inducing Chemotherapy in Liver Cancer
- (2018) Kristina Kovacovicova et al. Frontiers in Oncology
- Senescence and aging: Causes, consequences, and therapeutic avenues
- (2017) Domhnall McHugh et al. JOURNAL OF CELL BIOLOGY
- The Clinical Potential of Senolytic Drugs
- (2017) James L. Kirkland et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Senescent cells: an emerging target for diseases of ageing
- (2017) Bennett G. Childs et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of HSP90 inhibitors as a novel class of senolytics
- (2017) Heike Fuhrmann-Stroissnigg et al. Nature Communications
- Cellular senescence drives age-dependent hepatic steatosis
- (2017) Mikolaj Ogrodnik et al. Nature Communications
- The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
- (2017) Sophie Cazanave et al. Scientific Reports
- Cellular Senescence: A Translational Perspective
- (2017) James L. Kirkland et al. EBioMedicine
- Disease drivers of aging
- (2016) Richard J. Hodes et al. Annals of the New York Academy of Sciences
- DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression
- (2016) M. Borghesan et al. CANCER RESEARCH
- Senescence in chronic liver disease: Is the future in aging?
- (2016) Aloysious D. Aravinthan et al. JOURNAL OF HEPATOLOGY
- The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
- (2015) Yi Zhu et al. AGING CELL
- Liver diseases and aging: friends or foes?
- (2013) Fareeba Sheedfar et al. AGING CELL
- Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma
- (2013) Francesca Rappa et al. PLoS One
- Effect of preoperative chemotherapy on postoperative liver regeneration following hepatic resection as estimated by liver volume
- (2013) Daiki Takeda et al. World Journal of Surgical Oncology
- Aging, Cellular Senescence, and Cancer
- (2012) Judith Campisi Annual Review of Physiology
- DNA Methyltransferases 1 and 3b Expression in Huh-7 Cells Expressing HCV Core Protein of Different Genotypes
- (2012) Giorgia Benegiamo et al. DIGESTIVE DISEASES AND SCIENCES
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started